soyasaponin Ab

isolated from soybean; structure in first source

Networked: 3 relevant articles (1 outcomes, 1 trials/studies)

1.	Colitis 12/28/2011 - "On the basis of these findings, soyasaponin Ab may ameliorate colitis by inhibiting the binding of LPS to TLR4 on macrophages." 12/28/2011 - "Soyasaponin Ab ameliorates colitis by inhibiting the binding of lipopolysaccharide (LPS) to Toll-like receptor (TLR)4 on macrophages."
2.	Postmenopausal Osteoporosis 01/01/2018 - "These in vitro and in vivo study results demonstrated that GSGE and soyasaponin Ab have potential as therapeutic candidate agents for bone protection in postmenopausal osteoporosis."
3.	Acute Lung Injury 01/01/2016 - "Soyasaponin Ab inhibits lipopolysaccharide-induced acute lung injury in mice."
4.	Osteoporosis 01/01/2018 - "Germinated soy germ with increased soyasaponin Ab improves BMP-2-induced bone formation and protects against in vivo bone loss in osteoporosis."

1.	Lipopolysaccharides
2.	Toll-Like Receptors (Toll-Like Receptor)